TAC1, tachykinin precursor 1, 6863

N. diseases: 478; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain
0.060 Biomarker disease BEFREE Since the failure of specific substance P antagonists to induce analgesia, the role of tachykinins in the development of neuropathic pain states has been discounted. 31012376 2020
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain
0.060 Biomarker disease BEFREE Substance P modulates electroacupuncture analgesia in humanized mice with sickle cell disease. 31447579 2019
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain
0.060 Biomarker disease BEFREE LLLT analgesia is mediated by the antinociceptive signaling of intramuscular substance P and is associated with TRPV1 activation in a mouse model of fibromyalgia or chronic muscle pain. 30908578 2019
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain
0.060 Biomarker disease BEFREE We further suggest that therapeutic end points can be effectively and safely achieved when SP-PE35 is locally infused, thereby producing a regionally defined analgesia. 28814145 2018
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain
0.060 Biomarker disease BEFREE The results presented emphasize the potential of opioid/NK1 hybrids in view of analgesia under nerve injury conditions. 28699350 2017
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain
0.060 Biomarker disease BEFREE The aim of this study was to investigate whether expression of γ-aminobutyric acid (GABA) and the neuropeptides substance P (SP) and calcitonin gene-related peptide (CGRP) in the primary sensory neurons of cervical dorsal root ganglia (DRG) are involved in electroacupuncture (EA)-induced analgesia in a rat model of incisional neck pain. 28600329 2017